A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds

Details for Australian Patent Application No. 2001254997 (hide)

Owner CytRx Corporation

Inventors Schneiderne Barlay, Maria; Toth, Jozsef; Jegesne Csakai, Zita; Szakacsne Schmidt, Aniko; Gruber, Lajos; Urogdi, Laszlo; Reider, Ferencne; Tomoskozi, Dr. Istvan; Otvos, Laszlo

Agent Davies Collison Cave

Pub. Number AU-B-2001254997

PCT Pub. Number WO01/79174

Priority 0001583 18.04.00 HU

Filing date 17 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 23 November 2006

International Classifications

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

23 November 2006 Application Accepted

  Published as AU-B-2001254997

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Biorex Kutato es Fejileszto The name of the applicant has been changed to CytRx Corporation

22 March 2007 Standard Patent Sealed

31 May 2012 Assignment Registered

  Cytrx Corporation The patent has been assigned to Orphazyme ApS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001254998

2001254995